MAY 30, 2014 10:30 AM PDT

Universal Definition of MI

Speaker
  • Director, Scientific Affairs Cardiac, Roche Diagnostics Corporation
    Biography
      Hans-Juergen Loyda, Ph.D., MBA, is Director of Clinical Development and Education of Medical and Scientific Affairs at Roche Diagnostics in Indianapolis. He holds a Bachelor of Science in Biology, a Doctorate in Zoology from the Rheinisch-Friedrichs-Wilhelms University in Bonn/Germany and a Master of Business Administration from the Indiana Wesleyan University. He has been with Roche Diagnostics for 28 years with extensive experience in sales and marketing. The last 8 years he has focused on developing relevant and compelling clinical evidence for cardiac biomarker in Medical & Scientific Affairs. For this area he is also scientific resource internally and externally.

    Abstract

    The program "The Universal Definition of MI & Troponin, Clearing the confusion" is intended to review the recently released Third Universal Definition of Myocardial Infarction and aims to familiarize clinicians and laboratory health care providers with the implications for current practice.

    The focus will be on understanding the use of troponin in the Clinical Setting and my discussions will include:

    • The identification of pathological characteristics of myocardial ischemia and infarction,
    • The classification framework created by the 2007 Universal Definition of MI,
    • The biomarker preference and endorsement of cardiac troponins as preferred biomarker for each category of MI emphasizing that an increased troponin concentration is defined as a value exceeding the 99th percentile of a normal reference population, and
    • The differentiation of acute and chronic cTn elevations.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    MAY 30, 2014 10:30 AM PDT

    Universal Definition of MI


    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources